tiprankstipranks
Oramed Pharmaceuticals (ORMP)
NASDAQ:ORMP
US Market

Oramed Pharm (ORMP) Income Statement

Compare
514 Followers

Oramed Pharm Income Statement

Last quarter (Q3 2024), Oramed Pharm's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Oramed Pharm's net income was $-19.62M. See Oramed Pharm’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Sep 21Sep 20Sep 19
Total Revenue
$ 1.34M$ 2.70M$ 2.70M$ 2.71M$ 2.70M
Gross Profit
$ 1.34M$ 2.70M$ 2.70M$ 2.62M$ 2.61M
Operating Expenses
$ 17.11M$ 43.30M$ 26.93M$ 14.47M$ 17.24M
Depreciation and Amortization
$ 196.00K$ 3.62M$ 77.00K$ 7.00K$ 8.00K
EBITDA
$ -15.57M$ -36.98M$ -25.04M$ -11.31M$ -14.17M
Operating Income
$ -15.77M$ -40.60M$ -24.22M$ -11.76M$ -14.63M
Other Income/Expenses
$ 20.86M$ 2.93M$ 893.00K$ -438.00K$ -450.00K
Pretax Income
$ 5.09M$ -37.66M$ -22.99M$ -11.51M$ -14.05M
Net Income
$ 5.53M$ -37.76M$ -22.24M$ -11.51M$ -14.36M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.14$ -0.97$ -0.78$ -0.56$ -0.82
Diluted EPS
$ 0.14$ -0.97$ -0.78$ -0.56$ -0.82
Weighted Average Shares Outstanding
40.32M 39.00M 28.47M 20.53M 17.45M
Weighted Average Shares Outstanding (Diluted)
40.57M 39.00M 28.47M 20.53M 17.45M
Currency in USD

Oramed Pharm Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis